Previous 10 | Next 10 |
home / stock / seovf / seovf news
(via TheNewswire) LONDON, ONTARIO - TheNewswire - September 10, 2019 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) announces it has completed on Monday a non-brokered private placement of $4.685 million, pursuant to which Sernova issued a total of 23,422,822 Units in...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - September 3, 2019 - Sernova Corp. (TSXV:SVA) (FSE:PSH) (OTC:SEOVF), a clinical-stage regenerative medicine company, is pleased to announce that it has completed a second closing of $2,251,065 of its non-brokered private ...
(via TheNewswire) Offering Increased to $3,500,000 LONDON, ONTARIO - TheNewswire - August 19, 2019 - Sernova Corp. (TSXV:SVA) (FSEPSH) (OTC:SEOVF), a clinical-stage regenerative medicine company, is pleased to announce that it has completed a first closing of $2,3...
(via TheNewswire) L ondon, Ontario - TheNewswire - July 25, 2019 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) announces a proposed private placement (the "Offering") of up to $3 million in units (the "Units") of the Company at a price of $0.20 per Unit includin...
(via TheNewswire) CEO to participate in conference call with Sernova Shareholders on July 18 at 10:00 am (EDT) LONDON, ONTARIO - TheNewswire - July 17, 2019 - Sernova Corp. (TSXV:SVA) (FSE:PSH) (OTCQB:SEOVF), a clinical-stage regenerative medicine company today an...
(via TheNewswire) Sernova's Cell Pouch (TM) with transplanted islet cells reached primary safety measurements and clinically significant efficacy outcomes including glucose-stimulated C-peptide and the release of insulin in the first patient transplanted LONDON, ONTAR...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 27, 2019 - Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF), a clinical-stage regenerative medicine company is pleased to announce that Dr. Piotr Witkowski, Director of Pancreatic, and Islet Transplant Program at the University ...
(via TheNewswire) LONDON, ONTARIO / TheNewswire / May 21 , 2019 - Sernova Corp. (TSX-V: SVA) (OTCQB: SEOVF) a clinical-stage regenerative medicine company, today announced the appointment of Ms. Deborah Brown to its Board of Directors. Ms. Brown has extensive ...
(via TheNewswire) Co-investigators, Dr. Sam Wiseman of the University of British Columbia and Sernova Corp awarded the prestigious Transplant Research Foundation of British Columbia Venture Grant LONDON, ONTARIO / TheNewswire / April 30, 2019 - Sernova Corp. (TSX-...
(via TheNewswire) LONDON, ONTARIO / TheNewswire / April 11, 2019 - Sernova Corp. (TSX-V: SVA) (OTCQB: SEOVF), a clinical-stage regenerative medicine company today announced the first Cell Pouch(TM) transplant of insulin-producing cells in its U.S. Phase I/II clinical trial...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...